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ABSTRACT
This study aimed to investigate the mechanism of rice bran oil on altering lipid absorption and blood 
lipid level in normal rat. Male Sprague Dawley rat age 3 months old, weighted 250–300 g were grouped 
into three groups: control (aquabidest 1 ml), orlistat (2.16 mg / 200 g body weight), and rice bran oil 
(1.04 mg γ-oryzanol / 200 g body weight). The intervention was given through oral gavage, daily for 
28 days. Indicators observed were growth performance, total cholesterol and serum triglyceride levels, 
lipid levels in feces, and accumulation of intra-abdominal fat. The results showed that the treatment did 
not significantly affect body weight gain. Fecal lipid levels of orlistat, rice bran oil and control group 
respectively were 0.19g; 0.17g and 0.13 g (p<0.05), while the percentage of indigestible lipids for 
orlistat, control and rice bran oil group were 26%, 17% and 13% respectively (p<0.05). Total cholesterol 
and serum triglyceride levels in rice bran oil group were significantly lower than controls. Rice bran oil 
did not significantly affect the percentage of total intra-abdominal fat and the weight of the heart and 
kidney (p>0.05). The intervention of rice bran oil was shown to reduce blood cholesterol and triglyceride 
levels in normal mice and did not accumulate intra-abdominal fat. The results suggest that rice bran oil 
might have an effect on blood lipid regulation but not by preventing lipid absorption. 
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INTRODUCTION
Lipid accumulation especially in abdominal 
adipose tissue might disrupt lipid metabolism 
and is often associated with main risk factors 
of degenerative diseases such as type 2 diabetes 
mellitus, hypertension, cardiovascular diseases, 
and dyslipidemia (Golay & Ybarra 2005; Kotchen 
2010; Akil & Ahmad 2011; Klop et al. 2013). 
Rice bran has been acknowledged as one of 
natural remedies for prevention of degenerative 
diseases, due to its functional components such 
as antioxidants, dietary fiber, vitamins, essential 
minerals, and enzyme inhibitors (Hamada 2000). 
The antioxidant capacity of rice bran is 28.74 
AEAC, 15 times more than tomato juice that has 
1.87 AEAC (Damayanthi et al. 2010).
Oil can be extracted from rice bran which 
constitutes up to 18–22% of oil. Rice bran oil 
has slightly sweet taste due to a high content of 
4-monomethylsterols (Cicero & Derosa 2005). It 
is readily sold in supermarket thus can easily be 
used to substitute palm oil. Rice bran oil contains 
γ-oryzanol, a mixture of ferulic acid esters of 
phytosterols and triterpene alcohols, as bioactive 
compound which has high antioxidant capacity 
(Damayanthi et al. 2004). Previous studies 
showed that rice bran oil significantly lowered 
total cholesterol and serum LDL on rats with 
hypercholesterolemia (Tong et al. 2014; Most et 
al. 2005).
It is hypothesized that the serum lipid 
lowering effect from rice bran oil is due to its 
γ-oryzanol content, not from its dietary fiber or fatty 
acid composition, that inhibit lipid absorption in 
small intestines and excrete it through feces (Ijiri 
et al. 2015). Study by Bhaskaragoud et al. (2016) 
showed that γ-oryzanol from rice bran oil affect 
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lipid absorption by decreasing intestinal lipase 
activity. Thus, the amount of lipid absorbed also 
reduced. However, a more detailed mechanism of 
action of the lipase inhibitor of rice bran oil has 
not been described. 
In this study we examined the effect of 
rice bran oil on inhibition of lipid absorption 
compared to orlistat (lipase inhibitor drug). To 
evaluate lipid absorption of rats fed with standard 
diet with addition of rice brain oil or orlistat, 
we examined rat’s growth performance, fecal 
lipid content, serum lipid profile, and the intra-
abdominal fat accumulation.
METHODS
Design, location, and time
This study was an experimental study 
using a Randomized Block Design (RBD). 
Animal intervention was conducted at IPB 
Veterinary Teaching Hospital, IPB University. 
Lipid serum analysis, fecal lipid analysis, and 
organs weighing were performed at Laboratory 
of Food Analysis and Chemistry of Department 
of Community Nutrition of IPB University. The 
study was conducted from April to November 
2018. The experiment obtained ethical clearance 
from Ethics Commission of IPB Veterinary 
Teaching Hospital, IPB University number 093/
KEH/SKE/VIII/2018.
Materials and tools
Twenty-one male Sprague Dawley rats at 
3 month of age were purchased from Tropical 
Biopharmaca Research Center of IPB University. 
Rice bran oil (Oryza Grace®) was obtained from 
supermarket in Bogor. Orlistat (Xenical®) was 
obtained from pharmacy in Bogor. Control diet 
was from Indonesia Formula Feed (Indonesia 
Formula Feed). Blood lipid profile analysis 
used the Cholesterol Reagent Kit (DiaSys) and 
Triglyceride Reagent Kit (DiaSys). Fecal lipid 
analysis used the Soxhlet method with hexane 
as solvent. Body weight and the weight of intra-
abdominal fat, kidney, heart, and liver were 
measured by digital scale.
Procedure
Animals and treatment. The rats were 
individually housed in wired-bottomed aluminum 
cage (170x170x240 mm) and provided with water 
and control diet ad libitum. The room temperature 
was maintained at 25°C with 12 hours dark and 
12 hours light period every day. The adaptation 
period was 7 days, followed by random 
assignment of the rats into three groups on day 8: 
1. control diet (energy 2,750 kcal/100g, 4% fat, 
23% crude protein, 17% digestible crude protein, 
5% crude fiber) and 1 ml of aquabidest; 2. control 
diet and orlistat with dose of 10.8 mg/kg BB; 3. 
control diet and rice bran oil with dose of 57.6 mg 
γ-oryzanol/day. Orlistat solution was prepared by 
diluting 64.8 mg of crushed orlistat tablet into 100 
ml of 1% Na-CMC to obtain final orlistat content 
of 0.0648%. Concentration of orlistat solution 
given to rat was adjusted weekly according to its 
body weight. Final volume given to rat was not 
exceeding 5 ml. Treatment was given daily for 
28 days. Aquabidest, orlistat, and rice bran oil 
were given through oral gavage daily at 9 am. 
Body weight was measured every week. Feed 
intake was measured every day.  Feed efficiency 
were calculated as proportion of feed intake 
to body weight gain. All rats were euthanized 
under anesthesia. Blood was collected through 
the jugular vein. The liver, heart, adipose tissues 
(mesenteric, retroperitoneal, and epididymal), 
and kidney were collected and weighed. Fecal 
samples were collected during last 4 days of the 
experiment. 
Serum Lipid Profile Analysis. The level of 
triglycerides and total cholesterol were measured 
using reagent kit (DiaSys) according to the 
manufacturer’s procedure. 
Determination of lipid content of feces. 
Fat content of feces were measured using Sohxlet 
method. Feces from the last four days were dried 
in the oven, then grinded and homogenized. 
Homogenized fecal sample for analysis were 
sampled (2 g/sample) using AOAC Official 
Method 925.08 sampling method. Hexane was 
used as solvent and heating process was running 
for 6 hours. Fat content was calculated as 
percentage of amount of lipid extracted to sample 
weight. 
Data analysis 
Data were expressed as means±SEM. 
Analysis for body weight difference pre and post 
intervention was performed using paired sample 
t-test. Feed intake, organ weight, and serum 
lipid profile were analyzed using ANOVA. All 
statistics analyses were performed with SPSS 
version 22.0 for Windows. 
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RESULTS AND DISCUSSION
Effect of rice bran oil (RBO) on rat growth 
performance
The effect of RBO on body weight gain, 
average calorie intake, feed efficiency and lipid 
absorption are presented in Table 1. After 28 
days, total body weight gain of RBO group was 
not different from the control group. Although 
the daily calorie intake between groups did not 
differ significantly, daily lipid intake of RBO 
group was significantly higher than other groups. 
This is resulted from the induction of RBO that 
contributed to additional lipid intake. Both RBO 
and Orlistat group have higher fecal lipid content.
In this study we observed that in normal 
physiology state, RBO will not result in 
significant body weight gain. This finding is in 
line with previous study which showed that rats 
intervened with High Fat Diet (HFD) did not 
lead to excessive body weight gain when given 
RBO orally along with the diet (Son et al. 2009). 
Moreover, study in normal rats fed either standard 
diet or rice bran containing diet showed a similar 
growth performance (Iijiri et al. 2015). 
It is known that γ-oryzanol might affect 
lipid absorption which reflected on the number of 
fecal lipid content. Statistical test results showed 
that the Orlistat and RBO group had significantly 
more fecal lipid content than the control group. 
As it is expected from Orlistat which known to 
act as inhibitor of the pancreatic lipase enzyme, 
the increase in fecal lipid content of RBO group 
is thought to have different mechanism than 
Orlistat. The average percentage of absorbed 
lipid for control, orlistat, and RBO group is 
83.49±0.71%, 73.75±1.34%, and 86.96±0.27% 
respectively. This data show that the amount of 
lipid absorbed for RBO group was similar to the 
control group. Thus, unlike orlistat, the lipase 
enzyme in RBO group is not inhibited. Lipid 
absorption inhibition is more prominent to rats 
when fed with whole rice bran oil, so it might be 
due to the effect of insoluble fiber included in rice 
bran than γ-oryzanol (Iijiri et al. 2015). Possible 
explanation for higher fecal lipid content might 
result from higher lipid intake. Therefore, in 
this study RBO is not effective to prevent lipid 
absorption in the intestines.   
Effect of RBO on serum lipid profile
The effect of RBO on the total cholesterol 
and triglyceride level are presented in Table 2. 
RBO has significantly lower total cholesterol and 
triglycerides level than the control. Moreover, the 
low level was comparable to Orlistat treatment. 
This blood lipid lowering effect might be due to 
γ-oryzanol content in RBO.
It is known that γ-oryzanol is able to 
inhibit cholesterol and triglycerides absorption 
in the intestines and excrete it into feces (Rong 
et al. 1997; Wilson et al. 2007). However, as 
mentioned previously, we found that RBO 
group showed to have higher percentage of 
Parameter Control (n=5) Orlistat (n=5) RBO (n=5)
Growth Performance
Body weight gain (g/28 days) 25.20±8.40a 6.40± 9.54a 20.00±8.23a
Calorie intake (kcal/day) 550.00±81.10a 521.30±51.60a 491.20±72.40a
Feed efficiency 0.04±0.01a 0.01±0.02a 0.04±0.02a
Lipid Absorption
Lipid intake (g/day) 0.80±0.33a 0.76±0.36a 1.29±0.28b
Fecal lipid content (g) 0.13±0.01b 0.19±0.01a 0.17±0.01a
Data are expressed as the mean± SEM; Different letters (a and b) indicate significant difference at p<0.05 in the one-way 
ANOVA; RBO: Rice Bran Oil
Table 1. Growth performance and lipid absorption
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lipid absorbed compared to control and orlistat. 
Therefore, assumption that γ-oryzanol prevent 
lipid absorption is ruled out. While in this study 
we cannot confirmed the number of cholesterols 
absorbed, γ-oryzanol can also target HMG-KoA 
reductase which suppresses mevalonate synthesis 
(Chithra et al. 2015). Reduction in mevalonate 
will eventually lower cholesterol level in plasma. 
We assumed the role of γ-oryzanol is more on 
regulating lipid metabolism instead of inhibiting 
lipid absorption.
Unlike saturated fat, total fat intake has 
proven to have no significant association with 
total cholesterol and triglyceride level (Joy et 
al. 2007). Rice bran oil composed of mostly 
unsaturated fatty acids (75%) compared to 
saturated fatty acids (25%). Thus, even though 
supplementation of RBO increase the total fat 
intake, effect on blood lipid profile distortion is 
low.  Along these lines, beneficial effect of RBO 
on improving plasma lipid level can also be seen 
in normal physiology state.  
Effect of RBO on tissue weight
Rats in the RBO group tend to have lower 
intra-abdominal adipose tissue (1.11±0.45%bw) 
compare to control (1.41±0.18%bw) and orlistat 
(1.23±0.24%bw) group as shown in Table 3. 
However, these differences are not significant. 
This finding is in line with previous studies which 
showed that oryzanol is able to significantly 
decreased epididymal, mesenteric, and peritoneal 
fat, but not kidney and heart (Wang et al. 2015; 
Iijiri et al. 2015; Charkonpunya 2010; Kobayashi 
et al. 2019).
Mechanism on how RBO able to prevent 
lipid accumulation is still unknown. However, 
study by Yang et al. (2019) found that rice bran 
can alleviate adiposity by partially reducing 
the increase of diglycerides and triglycerides in 
obese rats. Furthermore, study on molecular level 
shows that RBO down-regulate lipogenic genes, 
such as Sod1 and Cat, which reduce hepatic level 
of triacylglycerol (Ahmed et al. 2018). This result 
suggests that RBO has some roles in regulating 
Table 3. Effect on tissue weight 
Parameter Control (n=5) Orlistat (n=5) RBO (n=5)
Final Body Weight (g) 305.80±7.70b 278.40±15.98a 290.30±9.35a
Total intra-abdominal fat (%bw) 1.41±0.18a 1.23±0.24a 1.11±0.45a
Mesenteric fat (%bw) 0.34±0.08a 0.24±0.05a 0.28±0.14a
Retroperitoneal fat (%bw) 0.34±0.18a 0.31±0.14a 0.25±0.24a
Epididymal fat (%bw) 0.73±0.09a 0.68±0.17a 0.58±0.25a
Kidney (%bw) 0.69±0.04a 0.64±0.04a 0.68±0.08a
Heart (%bw) 0.32±0.02a 0.32±0.04a 0.30±0.02a
Data are expressed as the mean±SEM; Different letters (a and b) indicate significant difference at p<0.05 in the one-way 
ANOVA; %bw = % body weight; RBO: Rice Bran Oil
Table 2. Blood lipid profile
Parameter Control (n=5) Orlistat (n=5) RBO (n=5)
Total Cholesterol (mg/dl) 57.99± 0.99a 48.15±0.03b 46.89±0.20b
Triglyceride (mg/dl) 65.30±0.74a 50.96±0.26b 53.06±0.43b
Data are expressed as the mean±SEM; Different letters (a and b) indicate significant difference at p<0.05 in the one-way 
ANOVA; RBO: Rice Bran Oil
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adiposity. Further studies are necessary to confirm 
this mechanism.
CONCLUSION
Beneficial effect of RBO supplementation 
on blood lipid level in this study does not derived 
from inhibition of lipid absorption. While 
the exact mechanism is still unknown, RBO 
supplementation in normal physiology did not 
affect both final body weight and tissue weight of 
intra-abdominal fat, kidney, and heart. This study 
was performed in rat thus careful interpretation 
is needed when translating this study result into 
human subject.
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